Showing results (1371-1380 of 5,501) with videos related to

Sort By:
Pageof 551
Inflammatory Bowel Diseases|July 20, 2002
Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activityUrban Sjöqvist, Erik Hertervig, Ake Nilsson, et al.
Inflammatory Bowel Diseases|November 27, 2001
Hepatitis B and C virus infection in Crohn's diseaseL Biancone, M Pavia, G Del Vecchio Blanco, et al.
Inflammatory Bowel Diseases|November 27, 2001
Clinical outcome of Crohn's disease: analysis according to the vienna classification and clinical activityF T Veloso, J T Ferreira, L Barros, et al.
Inflammatory Bowel Diseases|November 27, 2001
Proximal Crohn's disease: review of the clinicopathologic features and therapyR A van Hogezand, A M Witte, R A Veenendaal, et al.
Inflammatory Bowel Diseases|March 27, 2003
The effect of 5-aminosalicylic acid-containing drugs on sulfide production by sulfate-reducing and amino acid-fermenting bacteriaLaurie M Edmond, Mark J Hopkins, Elizabeth A Magee, et al.
Inflammatory Bowel Diseases|March 27, 2003
Experimental colitis in rats with portal hypertension and liver diseaseZvi Ackerman, Fanny Karmeli, Patrizia Cohen, et al.
Inflammatory Bowel Diseases|March 20, 2021
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical ProgramBruce E Sands, Millie D Long, Walter Reinisch, et al.
Inflammatory Bowel Diseases|November 18, 2021
Current Trends in IBD-Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling SystemYunki Y Yau, Valerie C Wasinger, Robert P Hirten, et al.
Inflammatory Bowel Diseases|November 18, 2021
Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel DiseasesYi Li, Jianping Chen, Andrew A Bolinger, et al.
Pageof 551